In this episode, Nazli Dizman and the Uromigos cover an update on the CBM588 probiotic strain and its phase II trial that combines the drug with ipilimumab and nivolumab to treat renal cancer. The data was presented at ASCO 2022. ...
The Uromigos: Microbiome
Hear Thomas Powles, MD, and Brian Rini, MD, FASCO, discuss research and news on the microbiome.
Advertisement
Tom and Brian take a look back at the year in kidney cancer with Dr. Toni Choueiri.
The Uromigos and Monty Pal discuss data on microbiome modification's impact on immune-oncology clinical efficacy in mRCC.
Advertisement
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.